Skip to main content
Premium Trial:

Request an Annual Quote

Glaxo Wellcome Is First Customer for Genomica's Gene Discovery Software


BOULDER, Colo.--Genomica announced that it has licensed its Discovery Manager Product Suite to Glaxo Wellcome. The bioinformatics software supports a range of research activities and provides data that can be used by pharmaceutical and biotechnology companies.

The software offers visualization and analysis tools, project management tools, and a comprehensive database of genetic information collected from the major international genome centers. Discovery Manager integrates the collected data through a process of semantic normalization which merges data that is represented around the world in a variety of ways into a common semantic model.

The software also brings comprehensive, integrated bioinformatics tools to the desktop and enables scientists to model the complex relationships among sets of genetic information, Genomica claimed. Discovery Manager maintains information on every aspect of the gene discovery process, from the clinical genetics work-up, to epidemiology, to genetic analysis, to molecular biology (both physical mapping and sequence analysis), to biochemistry.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.